Company news
Zymeworks Inc. news in 2020
Zymeworks Inc.'s news releases, calls and decks from 2020, newest first.
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration With BeiGene
November 30, 2020
Zymeworks Receives FDA Breakthrough Therapy Designation for HER2-Targeted Bispecific Antibody Zanidatamab in Patients with Biliary Tract Cancer
November 29, 2020
Zymeworks Receives Orphan Drug Designation From the European Commission for HER2-Targeted Bispecific Antibody Zanidatamab in Patients With Gastric Cancer
November 18, 2020
Zymeworks and ALX Oncology Announce Clinical Collaboration Evaluating Zanidatamab with the CD47 Blocker ALX148 in Patients with Advanced HER2‑Expressing Breast Cancer
November 15, 2020
Zymeworks Reports 2020 Third Quarter Financial Results
November 2, 2020
Zymeworks Reports 2020 Second Quarter Financial Results
August 4, 2020
Zymeworks Announces New Multispecific Antibody Collaboration with Merck
July 7, 2020
Zymeworks Announces Corporate Update Webcast and Conference Call
June 29, 2020
Zymeworks Reports 2020 First Quarter Financial Results
May 6, 2020
Zymeworks Announces First Patient Dosed in Phase 1b/2 Trial of ZW25 in First-Line HER2-Positive Breast Cancer and Gastroesophageal Adenocarcinoma Conducted by BeiGene
March 31, 2020
Zymeworks Appoints Dr. Kelvin Neu to the Board of Directors
March 15, 2020
Zymeworks Reports 2019 Year-End Financial Results
March 1, 2020
Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Over-Allotment Option to Purchase Additional Shares
January 26, 2020
Zymeworks Announces Pricing of $279.0 Million Public Offering
January 21, 2020
Zymeworks Files Preliminary Prospectus Supplements for Offering of Common Shares and Pre-Funded Warrants
January 20, 2020
Zymeworks Highlights 2019 Achievements and Announces Corporate Priorities
January 12, 2020
Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance® (palbociclib)
January 11, 2020
Decks in 2020
- Technical Presentation (November 2020)
Technical · 13 slides · Nov 16, 2020